Terumo Enhances Coronary Interventional Product Portfolio By Securing Exclusive Global Rights to Orchestra BioMed's Virtue® Sirolimus-Eluting Balloon (SEB) through Global Strategic Partnership

Author's Avatar
Jun 13, 2019
Article's Main Image

First and only non-coated drug-eluting angioplasty balloon that delivers a proprietary bioabsorbable, sustained-release formulation of sirolimus

PR Newswire